PLASMA LEVELS OF DEHYDROEPIANDROSTERONE AND 17BETA -ESTRADIOL AFTER INTRAMUSCULAR ADMINISTRATION OF GYNODIAN-DEPOT^REG. IN 3 WOMENDUSTERBERG B; WENDT H.1983; HORMONE RESEARCH; ISSN 0301-0163; CHE; DA. 1983; VOL. 17; NO 2; PP. 84-89; BIBL. 7 REF.Article

BIOVERFUEGBARKEIT VON CYPROTERONACETAT NACH ORALER UND INTRAMUSKULAERER APPLIKATION BEI MAENNERN = BIODISPONIBILITE DE L'ACETATE DE CYPROTERONE APRES APPLICATION ORALE ET INTRAMUSCULAIRE CHEZ LES HOMMESBECKER H; DUSTERBERG B; KLOSTERHALFEN H et al.1980; UROL. INT.; ISSN 0042-1138; CHE; DA. 1980; VOL. 35; NO 6; PP. 381-385; ABS. ENG; BIBL. 12 REF.Article

THE PROGESTATIONAL ACTIVITY OF DIFFERENT GESTAGENS USED FOR HUMAN CONTRACEPTION IN THE BEAGLE BITCHBEIER S; HAASE F; KOSUB B et al.1979; CONTRACEPTION; USA; DA. 1979; VOL. 20; NO 6; PP. 533-548; BIBL. 18 REF.Article

Pharmacokinetics and biotransformation of estradiol valerate in ovariectomized womenDÜSTERBERG, B; SCHMIDT-GOLLWITZER, M; HÜMPEL, M et al.Hormone research. 1985, Vol 21, Num 3, pp 145-154, issn 0301-0163Article

Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetateBURSCH, W; DÜSTERBERG, B; SCHULTE-HERMANN, R et al.Archives of toxicology. 1986, Vol 59, Num 4, pp 221-227, issn 0340-5761Article

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 μg gestodene, with respect to efficacy, cycle control, and toleranceENDRIKAT, J; MÜLLER, U; DÜSTERBERG, B et al.Contraception (Stoneham). 1997, Vol 55, Num 3, pp 131-137, issn 0010-7824Article

Half-lives in plasma and bioavailability of ethinylestradiol in laboratory animalsDÜSTERBERG, B; KÜHNE, G; TÄUBER, U et al.Arzneimittel-Forschung. 1986, Vol 36, Num 8, pp 1187-1190, issn 0004-4172Article

Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosteroneTÄUBER, U; SCHRÖDER, K; DÜSTERBERG, B et al.European journal of drug metabolism and pharmacokinetics. 1986, Vol 11, Num 2, pp 145-149, issn 0378-7966Article

Induction of monooxygenases and growth in rat liver by progesteroneOCHS, H; DUSTERBERG, B; SCHULTE-HERMANN, R et al.Archives of toxicology. 1986, Vol 59, Num 3, pp 146-149, issn 0340-5761Article

A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 30 μg ethinyl estradiol and 75 μg gestodene on hemostatic variables, lipids, and carbohydrate metabolismENDRIKAT, J; KLIPPING, C; GERLINGER, C et al.Contraception (Stoneham). 2001, Vol 64, Num 4, pp 235-241, issn 0010-7824Article

The effect on blood pressure of a monophasic oral contraceptive containing ethinylestradiol and gestodeneFUCHS, N; DÜSTERBERG, B; WEBER-DIEHL, F et al.Contraception (Stoneham). 1995, Vol 51, Num 6, pp 335-339, issn 0010-7824Article

A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinylestradiolWINKLER, U. H; SCHINDLER, A. E; ENDRIKAT, J et al.Contraception (Stoneham). 1996, Vol 53, Num 2, pp 75-84, issn 0010-7824Article

Inhibition of ovulation by a triphasic gestodene-containing oral contraceptiveSPONA, J; LACHNIT-FIXSON, U; DÜSTERBERG, B et al.Advances in contraception. 1993, Vol 9, Num 3, pp 187-194, issn 0267-4874Article

Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liverOCHS, H; DÜSTERBERG, B; GÜNZEL, P et al.Cancer research (Baltimore). 1986, Vol 46, Num 3, pp 1224-1232, issn 0008-5472Article

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variablesENDRIKAT, J; KLIPPING, C; CRONIN, M et al.Contraception (Stoneham). 2002, Vol 65, Num 3, pp 215-221, issn 0010-7824Article

Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparationsENDRIKAT, J; NOAH, M; GERLINGER, C et al.Contraception (Stoneham). 2001, Vol 64, Num 4, pp 217-222, issn 0010-7824Article

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical studyENDRIKAT, J; DÜSTERBERG, B; RUEBIG, A et al.Contraception (Stoneham). 1999, Vol 60, Num 5, pp 269-274, issn 0010-7824Article

Biotransformation of proterguride in the perfused rat liverKRAUSE, W; DÜSTERBERG, B; JAKOBS, U et al.Drug metabolism and disposition. 1993, Vol 21, Num 2, pp 203-208, issn 0090-9556Article

A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 μg or 30 μg ethinylestradiol in combination with levonorgestrel on bone mineral densityENDRIKAT, J; MIH, E; DÜSTERBERG, B et al.Contraception (Stoneham). 2004, Vol 69, Num 3, pp 179-187, issn 0010-7824, 9 p.Article

Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrelENDRIKAT, J; CRONIN, M; GERLINGER, C et al.Contraception (Stoneham). 2001, Vol 64, Num 3, pp 201-207, issn 0010-7824Article

Double-blind, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 μg ethinyl estradiol and 75 μg gestodeneENDRIKAT, J; CRONIN, M; GERLINGER, C et al.Contraception (Stoneham). 2001, Vol 64, Num 2, pp 99-105, issn 0010-7824Article

A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive useENDRIKAT, J; GERLINGER, C; PLETTIG, K et al.Gynecological endocrinology. 2003, Vol 17, Num 2, pp 107-114, issn 0951-3590, 8 p.Article

Shorter pill-free interval in combined oral contraceptives decreases follicular developmentSPONA, J; ELSTEIN, M; FEICHTINGER, W et al.Contraception (Stoneham). 1996, Vol 54, Num 2, pp 71-77, issn 0010-7824Article

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel, with respect to efficacy, cycle control and toleranceENDRIKAT, J; JAQUES, M.-A; MAYERHOFER, M et al.Contraception (Stoneham). 1995, Vol 52, Num 4, pp 229-235, issn 0010-7824Article

Norethisterone acetate and ethinylestradiol in early human pregnancyPULKKINEN, N. O; DUSTERBERG, B; HASAN, H et al.Teratology (Philadelphia, PA). 1984, Vol 29, Num 2, pp 241-249, issn 0040-3709Article